Request Clinical Starter Kits for Your Patients Today! Request Now

 Blood Sugar and Insulin STUDIES

Compared to oral berberine, oral dihydroberberine achieves a higher blood berberine level with lower doses, study shows

Highlights Berberine supplementation has therapeutic value for glycemic control, but digestive upset and poor patient compliance is common. Compared to high-dose berberine (500 mg), low-dose dihydroberberine (100 or 200 mg) significantly (p<.05)...
on January 23, 2024

Tocotrienols as adjunct therapy for chronic diseases, a comprehensive review

Highlights Includes over 3 decades of published research (preclinical & human studies) Research related to common diseases addressed Applications for cardiovascular, cerebrovascular, neurodegenerative diseases & more Summary This comprehensive review...
on February 25, 2020

The Effect of ENDUR-AMIDE® on Type 1 Diabetes Prevention in School Children: An 8-Year Study

Highlights ENDUR-AMIDE® may help delay the onset of type 1 diabetes in young children. Treatment dosage was 500 mg, twice daily Excellent compliance (over 90%) with treatment Summary This clinical...
on February 25, 2020

Resveratrol significantly improves glycemic control in people with diabetes, meta-analysis shows

Highlights Meta-analysis with 11 randomized, controlled clinical trials comprising 388 subjects In people with diabetes, resveratrol significantly improves glucose control and insulin sensitivity. Median intake is 100 mg/day for 12...
on February 25, 2020

ResVida® resveratrol exerts beneficial effects on metabolism in obese men, study shows

Highlights Randomized, double-blind, placebo-controlled, cross-over trial with 11 obese, but otherwise healthy men. Supplementation consists of resVida® resveratrol (150 mg/day for 30 days) Compared to placebo, resVida® induces significant metabolic...
on February 25, 2020